ANIX logo

ANIX

Anixa Biosciences Inc.

$2.99
-$0.02(-0.66%)
20
Overall
--
Value
20
Tech
--
Quality
Market Cap
$96.31M
Volume
19.45K
52W Range
$2.07 - $4.20
Target Price
$9.00
Order:

Income Statement

MetricTrendChart
2015
Oct
2016
Oct
2017
Oct
2018
Oct
2019
Oct
2020
Oct
2021
Oct
2022
Oct
2023
Oct
2024
Oct
REVENUE
Total Revenue
$9.3M$300.0K$362.5K$1.1M$250.0K--$512.0K--$210.0K$210.0K
Total Revenue
$9.3M$300.0K$362.5K$1.1M$250.0K--$512.0K--$210.0K$210.0K
COST OF GOODS SOLD
Cost of Revenue
$3.5M$106.2K$-6.4M$-15.4M$-12.1M$10.0M$385.0K$13.9M$161.0K--
GROSS PROFIT
Gross Profit
$5.8M$193.8K$362.5K$1.1M$250.0K$-10.0M$127.0K$-13.9M$210.0K$210.0K
OPERATING EXPENSES
Operating Expenses
$6.7M$4.7M$6.4M$14.8M$11.7M$10.0M$13.6M$13.9M$11.2M$13.8M
Research & Development
$711.4K$1.6M$1.6M$6.8M$5.5M$4.4M$6.2M$6.7M$4.8M$6.4M
Research Expense
$711.4K$1.6M$1.6M$6.8M$5.5M$4.4M$6.2M$6.7M$4.8M$6.4M
Selling, General & Administrative
$5.5M$2.7M$4.4M$6.9M$5.7M$5.6M$7.1M$7.2M$6.3M$7.4M
Selling & Marketing Expenses
$5.5M$2.7M$4.4M$6.9M$5.7M----------
General & Administrative Expenses
$-100.0K$-188.0K$-229.0K$-114.0K$5.7M$5.6M$7.1M$7.2M$6.3M$7.4M
Salaries & Wages
--$-873.6K$1.7M$8.9M$-3.6M$-3.9M----$4.4M$4.4M
Depreciation & Amortization
$325.3K$325.3K$325.3K$325.3K$418.8K$-38.3K--------
Depreciation & Amortization
$325.3K$325.3K$325.3K$325.3K$418.8K$-38.3K--------
Amortization
$325.3K$325.3K$325.3K$325.3K$418.8K----------
Other Operating Expenses
$147.7K$111.2K$104.6K$768.4K$166.3K$5.8M$385.0K$7.2M$161.0K$13.8M
OPERATING INCOME
Operating income
$-944.8K$-4.5M$-6.1M$-13.7M$-11.5M$-10.0M$-13.1M$-13.9M$-11.0M$-13.8M
EBITDA
$-589.3K$-4.1M$-4.1M$-13.9M$-11.4M$-9.9M$-13.1M$-13.8M$-748.9M$-13.8M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$451.9K$519.9K$500.5K--------------
Intinc
$17.6K$12.5K$19.4K$46.0K$71.4K$33.9K$2.0K$104.0K$1.1M$1.1M
Net Non-Operating Interest Income/Expense
$-434.3K$-507.4K$-481.0K$46.0K$71.4K$33.9K$2.0K$104.0K$1.1M$1.1M
Other Income/Expense
$-19.2K--$-1.5M$583.0K$418.8K$148.1K$-6.0K------
Other Special Charges
$19.2K--$1.5M--------------
SPECIAL ITEMS
Special Income Charges
$3.6M--------------$-210.0K--
Other Impairment Of Capital Assets
------$583.0K$418.8K----------
PRE-TAX INCOME
EBIT
$-927.1K$-4.5M$-4.5M$-14.2M$-11.8M$-10.0M$-13.1M$-13.9M$-748.9M$-13.8M
Pre-Tax Income
$-1.4M$-5.0M$-5.0M$-14.2M$-11.8M$-10.1M$-13.1M$-13.8M$-9.9M$-12.7M
INCOME TAX
Tax Provision
$-607.0K$-1.8M$-19.0M$-3.0M$-1.9M$-800.0K$-917.0K$-1.0B$-739.0M$-2.3B
NET INCOME
Net Income
$-1.4M$-5.0M$-5.0M$-14.0M$-11.6M$-10.0M$-13.0M$-13.6M$-9.8M$-12.6M
Net Income (Continuing Operations)
$-1.4M$-5.0M$-5.0M$-14.0M$-11.6M$-10.0M$-13.0M$-13.8M$-9.9M$-12.7M
Net Income (Discontinued Operations)
$-1.4M$-5.0M$-5.0M$-14.0M$-11.6M$-10.0M$-13.0M$-13.6M$-9.8M$-12.6M
Net Income (Common Stockholders)
$-1.4M$-5.0M$-7.0M$-14.0M$-11.6M$-10.0M$-13.0M$-13.6M$-9.8M$-12.6M
Normalized Income
------------$-14.1M------
TOTALS
Total Expenses
$10.2M$4.8M$6.4M$-583.0K$-418.8K$20.0M$27.3M$13.9M$11.2M$13.8M
SHARE & EPS DATA
Average Shares Outstanding
$8.8M$8.7M$12.2M$17.6M$19.8M$22.2M$28.6M$30.2M$31.0K$31.9K
Average Shares Outstanding (Diluted)
$86.2K$8.8M$8.6M$17.7M$19.7M$22.2M$28.6M$30.4M$31.0K$31.9K
Shares Outstanding
$8.7M$8.8M$16.6M$19.3M$20.8M$26.1M$30.1M$30.9M$32.2M$32.2M
Basic EPS
--------------$-0.45$-0.32$-0.39
Basic EPS (Continuing Operations)
--------------$-0.45$0.32$-0.39
Diluted EPS
$-16$-0.57$-0.58$-0.79$-0.59$-0.45$-0.45$-0.45$-0.32$-0.39
Diluted EPS (Continuing Operations)
----------$-0.45$-0.45--$0.32$-0.39
OTHER METRICS
Accrued Preferred Stock Dividends
----$2.0M--------------
Gain On Sale Of P P E
----------$-148.1K$6.0K------
Minority Interests
------$247.1K$171.6K$74.0K$174.0K$176.0K$119.0K$144.0K
Net Income From Other Gains Losses
----------$-148.1K--------
Non Recurring Operation Expense
$-3.6M--------------$210.0K--
Other Gand A
$-100.0K$-188.0K$-229.0K$-114.0K$5.7M$5.6M$7.1M$7.2M$6.3M$7.4M
Otherunder Preferred Stock Dividend
----$2.0M--------------
Preferred Stock Dividends
----$2.0M--------------
Rent And Landing Fees
$-100.0K$-188.0K$-229.0K$-114.0K$5.7M$-64.0K$-64.0K$-66.0K$-66.0K--
Selling Expense
$5.5M$2.7M$4.4M$6.9M$5.7M----------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2ANIX$2.99-0.7%19.45K
3
4
5
6

Get Anixa Biosciences Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.